SLAIN1 Activators are a collection of chemical compounds that strategically enhance SLAIN1's role in microtubule dynamics through targeted effects on various cellular pathways. Forskolin stands out by increasing intracellular cAMP, which in turn activates protein kinase A (PKA), possibly leading to the phosphorylation of proteins that work in concert with SLAIN1 to stabilize and promote microtubule assembly. This mechanism is complemented by PMA, which stimulates protein kinase C (PKC), affecting the phosphorylation states of proteins interacting with microtubules, thereby facilitating SLAIN1's role in microtubule stabilization. Epigallocatechin gallate, with its effect on several protein kinases, could relieve phosphorylation on proteins in the microtubule assembly pathway, augmenting SLAIN1's activity in this process. The PI3K LY294002 and Wortmannin, along with influencing Akt signaling, may indirectly foster an environment conducive to SLAIN1's enhancement of microtubule stability. Moreover, U0126 and SB203580, by targeting MEK1/2 and p38 MAPK respectively, could alter the phosphorylation landscape of microtubule-associated proteins, indirectly amplifying SLAIN1's stabilizing influence.
The modulation of calcium signaling through agents like A23187, which elevates intracellular calcium, and Thapsigargin, a SERCA pump, might activate calcium-dependent kinases that indirectly promote the microtubule regulatory function of SLAIN1. Sphingosine-1-phosphate, by acting on its specific receptors, leads to the activation of downstream kinases such as PKC, which may induce phosphorylation events bolstering SLAIN1's capacity to support microtubule growth. Genistein, by inhibiting tyrosine kinase activity, may decrease competition from tyrosine kinase signaling, which could clear the way for SLAIN1 to exert a more pronounced effect on microtubule dynamics. Staurosporine, despite its broad kinase inhibition profile, could paradoxically allow for a more selective activation of pathways that SLAIN1 is involved in by inhibiting kinases that otherwise temper microtubule-associated processes. Collectively, these SLAIN1 Activators, through their precise and varied influences on cellular signaling, serve to enhance the critical function of SLAIN1 in the maintenance and regulation of the microtubule cytoskeleton.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels in cells. Elevated cAMP activates PKA, which can phosphorylate various proteins including those in the microtubule dynamics pathway, thus potentially enhancing the microtubule stabilizing activity of SLAIN1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in a multitude of cellular processes, including the regulation of microtubule dynamics. PKC activation could lead to phosphorylation events that enhance SLAIN1 activity in microtubule stabilization. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This catechin inhibits various protein kinases, which may relieve inhibitory phosphorylation on proteins within the microtubule assembly pathway, potentially increasing the activity of SLAIN1 in promoting microtubule growth. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound is a p38 MAPK inhibitor. By inhibiting p38 MAPK, it could influence microtubule-associated protein kinases, potentially enhancing the activity of SLAIN1 by affecting the stability and dynamics of microtubules. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium-dependent kinases, which may indirectly enhance the microtubule regulatory function of SLAIN1. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Through its action on sphingosine-1-phosphate receptors, it can activate downstream kinases such as PKC, which could lead to the phosphorylation of proteins involved in microtubule dynamics, potentially enhancing the role of SLAIN1 in microtubule growth. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may reduce competitive phosphorylation on proteins within the microtubule dynamics pathway, thus favoring the microtubule stabilization processes that SLAIN1 enhances. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Although staurosporine is a broad-spectrum kinase inhibitor, it might promote microtubule stability by inhibiting kinases that negatively regulate microtubule-associated proteins, thereby potentially facilitating the activity of SLAIN1 in microtubule stabilization. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels. This can stimulate calcium-dependent signaling pathways affecting microtubule dynamics, thus potentially enhancing the stabilizing role of SLAIN1 on the microtubule network. | ||||||